{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T13:46:45Z","timestamp":1761659205713,"version":"build-2065373602"},"reference-count":62,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,3]],"date-time":"2022-01-03T00:00:00Z","timestamp":1641168000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Genetic Engineering and Biotechnology"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1186\/s43141-021-00282-4","type":"journal-article","created":{"date-parts":[[2022,1,3]],"date-time":"2022-01-03T07:03:43Z","timestamp":1641193423000},"page":"4","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["The role of BCL9 genetic variation as a biomarker for hepatitis C-related hepatocellular carcinoma in Egyptian patients"],"prefix":"10.1016","volume":"20","author":[{"given":"Eman Abd El Razek","family":"Abbas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed Barakat","family":"Barakat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed","family":"Hassany","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7114-4325","authenticated-orcid":false,"given":"Samar Samir","family":"Youssef","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1186\/s43141-021-00282-4_bib1","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0140-6736(18)30010-2","article-title":"Hepatocellular carcinoma","volume":"391","author":"Forner","year":"2018","journal-title":"Lancet (London, England)"},{"key":"10.1186\/s43141-021-00282-4_bib2","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1056\/NEJMra1713263","article-title":"Hepatocellular carcinoma","volume":"380","author":"Villanueva","year":"2019","journal-title":"The New England journal of medicine"},{"key":"10.1186\/s43141-021-00282-4_bib3","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1001\/jamaoncol.2017.3055","article-title":"The burden of primary liver cancer and underlying etiologies from 1990 to 2015 at the global, regional, and national level: results from the Global Burden of Disease Study 2015","volume":"3","author":"Akinyemiju","year":"2017","journal-title":"JAMA oncology"},{"key":"10.1186\/s43141-021-00282-4_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s43046-020-0016-x","article-title":"Hepatocellular carcinoma (HCC) in Egypt: a comprehensive overview","volume":"32","author":"Rashed","year":"2020","journal-title":"Journal of the Egyptian National Cancer Institute"},{"key":"10.1186\/s43141-021-00282-4_bib5","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1158\/1078-0432.CCR-14-0122","article-title":"Intratumor heterogeneity in hepatocellular carcinoma","volume":"21","author":"Friemel","year":"2015","journal-title":"Clinical Cancer Research"},{"key":"10.1186\/s43141-021-00282-4_bib6","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.canlet.2013.09.020","article-title":"\u03b2-Catenin signaling in hepatocellular cancer: implications in inflammation, fibrosis, and proliferation","volume":"343","author":"Lee","year":"2014","journal-title":"Cancer letters"},{"key":"10.1186\/s43141-021-00282-4_bib7","doi-asserted-by":"crossref","first-page":"936","DOI":"10.3892\/mco.2015.569","article-title":"\u03b2-catenin mutation is correlated with a favorable prognosis in patients with hepatocellular carcinoma","volume":"3","author":"Wang","year":"2015","journal-title":"Molecular and clinical oncology"},{"key":"10.1186\/s43141-021-00282-4_bib8","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1097\/MCG.0000000000000446","article-title":"Hepatocellular carcinoma screening and surveillance","volume":"50","author":"Zhao","year":"2016","journal-title":"Journal of clinical gastroenterology"},{"key":"10.1186\/s43141-021-00282-4_bib9","doi-asserted-by":"crossref","unstructured":"Ibrahim AS, Khaled HM, Mikhail NN, Baraka H, Kamel H (2014) Cancer incidence in Egypt: results of the national population-based cancer registry program. Journal of cancer epidemiology 2014. https:\/\/doi.org\/10.1155\/2014\/437971","DOI":"10.1155\/2014\/437971"},{"key":"10.1186\/s43141-021-00282-4_bib10","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.jnci.2016.06.001","article-title":"Prevalence of hepatocellular carcinoma in chronic hepatitis C patients in Mid Delta, Egypt: a single center study","volume":"28","author":"Ziada","year":"2016","journal-title":"Journal of the Egyptian National Cancer Institute"},{"key":"10.1186\/s43141-021-00282-4_bib11","doi-asserted-by":"crossref","first-page":"E359","DOI":"10.1002\/ijc.29210","article-title":"Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012","volume":"136","author":"Ferlay","year":"2015","journal-title":"International journal of cancer"},{"key":"10.1186\/s43141-021-00282-4_bib12","first-page":"69","article-title":"Global cancer statistics","volume":"61","author":"Jemal","year":"2011","journal-title":"CA: a cancer journal for clinicians"},{"key":"10.1186\/s43141-021-00282-4_bib13","first-page":"87","article-title":"Global cancer statistics, 2012","volume":"65","author":"Torre","year":"2015","journal-title":"CA: a cancer journal for clinicians"},{"key":"10.1186\/s43141-021-00282-4_bib14","doi-asserted-by":"crossref","first-page":"4326","DOI":"10.1158\/0008-5472.CAN-19-0803","article-title":"Recent developments and therapeutic strategies against hepatocellular carcinoma","volume":"79","author":"Yarchoan","year":"2019","journal-title":"Cancer research"},{"key":"10.1186\/s43141-021-00282-4_bib15","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/S0140-6736(18)30207-1","article-title":"Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial","volume":"391","author":"Kudo","year":"2018","journal-title":"The Lancet"},{"key":"10.1186\/s43141-021-00282-4_bib16","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1056\/NEJMoa0708857","article-title":"Sorafenib in advanced hepatocellular carcinoma","volume":"359","author":"Llovet","year":"2008","journal-title":"New England journal of medicine"},{"key":"10.1186\/s43141-021-00282-4_bib17","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.gene.2018.11.012","article-title":"Association between rs738409 polymorphism in patatin-like phospholipase domain-containing protein 3 (PNPLA3) gene and hepatocellular carcinoma susceptibility: evidence from case-control studies","volume":"685","author":"Li","year":"2019","journal-title":"Gene"},{"key":"10.1186\/s43141-021-00282-4_bib18","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.jhep.2012.02.035","article-title":"Single nucleotide polymorphisms and risk of hepatocellular carcinoma in cirrhosis","volume":"57","author":"Nahon","year":"2012","journal-title":"Journal of hepatology"},{"key":"10.1186\/s43141-021-00282-4_bib19","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.tig.2012.07.002","article-title":"Structural mutations in cancer: mechanistic and functional insights","volume":"28","author":"Inaki","year":"2012","journal-title":"Trends in Genetics"},{"key":"10.1186\/s43141-021-00282-4_bib20","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s13353-017-0407-4","article-title":"Clinical interpretation of copy number variants in the human genome","volume":"58","author":"Nowakowska","year":"2017","journal-title":"Journal of applied genetics"},{"key":"10.1186\/s43141-021-00282-4_bib21","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ajhg.2008.12.014","article-title":"Population analysis of large copy number variants and hotspots of human genetic disease","volume":"84","author":"Itsara","year":"2009","journal-title":"The American Journal of Human Genetics"},{"key":"10.1186\/s43141-021-00282-4_bib22","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s10549-010-1119-1","article-title":"MMP9 polymorphisms and breast cancer risk: a report from the Shanghai Breast Cancer Genetics Study","volume":"126","author":"Beeghly-Fadiel","year":"2011","journal-title":"Breast cancer research and treatment"},{"key":"10.1186\/s43141-021-00282-4_bib23","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1111\/j.1478-3231.2012.02822.x","article-title":"Higher risk of matrix metalloproteinase (MMP-2, 7, 9) and tissue inhibitor of metalloproteinase (TIMP-2) genetic variants to gallbladder cancer","volume":"32","author":"Sharma","year":"2012","journal-title":"Liver International"},{"key":"10.1186\/s43141-021-00282-4_bib24","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1038\/nm1009-1127","article-title":"Gene copy number: learning to count past two","volume":"15","author":"Shrestha","year":"2009","journal-title":"Nature medicine"},{"key":"10.1186\/s43141-021-00282-4_bib25","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.3892\/ol.2017.5567","article-title":"High expression of MMP9 in glioma affects cell proliferation and is associated with patient survival rates","volume":"13","author":"Xue","year":"2017","journal-title":"Oncology letters"},{"key":"10.1186\/s43141-021-00282-4_bib26","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1517\/14622416.3.2.229","article-title":"CYP2D6 allele frequency in European Caucasians, Asians, Africans and their descendants","volume":"3","author":"Bradford","year":"2002","journal-title":"Pharmacogenomics"},{"key":"10.1186\/s43141-021-00282-4_bib27","doi-asserted-by":"crossref","first-page":"130","DOI":"10.4132\/KoreanJPathol.2013.47.2.130","article-title":"Prognostic significance of BCL9 expression in hepatocellular carcinoma","volume":"47","author":"Hyeon","year":"2013","journal-title":"Korean journal of pathology"},{"key":"10.1186\/s43141-021-00282-4_bib28","doi-asserted-by":"crossref","first-page":"2808","DOI":"10.1002\/ijc.23901","article-title":"Clinical implication of recurrent copy number alterations in hepatocellular carcinoma and putative oncogenes in recurrent gains on 1q","volume":"123","author":"Kim","year":"2008","journal-title":"International journal of cancer"},{"key":"10.1186\/s43141-021-00282-4_bib29","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/01.fpc.0000239974.69464.f2","article-title":"CYP2D6 worldwide genetic variation shows high frequency of altered activity variants and no continental structure","volume":"17","author":"Sistonen","year":"2007","journal-title":"Pharmacogenetics and genomics"},{"key":"10.1186\/s43141-021-00282-4_bib30","first-page":"1","article-title":"Hypoxia activates Wnt\/\u03b2-catenin signaling by regulating the expression of BCL9 in human hepatocellular carcinoma","volume":"7","author":"Xu","year":"2017","journal-title":"Scientific reports"},{"key":"10.1186\/s43141-021-00282-4_bib31","doi-asserted-by":"crossref","unstructured":"Yu, X., Huang, J., Wu, S., Huang, Y., Shan, Y., and Lu, C. (2020) Copy number variations of MMP-9 are prognostic biomarkers for hepatocellular carcinoma, Translational Cancer Research 9, 698-706. 10.21037\/tcr.2019.11.52","DOI":"10.21037\/tcr.2019.11.52"},{"key":"10.1186\/s43141-021-00282-4_bib32","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/modpathol.3800107","article-title":"Analysis of DNA copy number aberrations in hepatitis C virus-associated hepatocellular carcinomas by conventional CGH and array CGH","volume":"17","author":"Hashimoto","year":"2004","journal-title":"Modern Pathology"},{"key":"10.1186\/s43141-021-00282-4_bib33","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1038\/sj.bjc.6602448","article-title":"Chromosome alterations in human hepatocellular carcinomas correlate with aetiology and histological grade\u2013results of an explorative CGH meta-analysis","volume":"92","author":"Moinzadeh","year":"2005","journal-title":"British journal of cancer"},{"key":"10.1186\/s43141-021-00282-4_bib34","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1002\/hep.510290410","article-title":"Novel recurrent genetic imbalances in human hepatocellular carcinoma cell lines identified by comparative genomic hybridization","volume":"29","author":"Zimonjic","year":"1999","journal-title":"Hepatology"},{"key":"10.1186\/s43141-021-00282-4_bib35","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0002-9440(10)65248-0","article-title":"Assessment of genetic changes in hepatocellular carcinoma by comparative genomic hybridization analysis: relationship to disease stage, tumor size, and cirrhosis","volume":"154","author":"Wong","year":"1999","journal-title":"The American journal of pathology"},{"key":"10.1186\/s43141-021-00282-4_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2407-8-199","article-title":"The function of BCL9 in Wnt\/\u03b2-catenin signaling and colorectal cancer cells","volume":"8","author":"De la Roche","year":"2008","journal-title":"BMC cancer"},{"key":"10.1186\/s43141-021-00282-4_bib37","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0092-8674(02)00679-7","article-title":"Wnt\/wingless signaling requires BCL9\/legless-mediated recruitment of pygopus to the nuclear \u03b2-catenin-TCF complex","volume":"109","author":"Kramps","year":"2002","journal-title":"Cell"},{"key":"10.1186\/s43141-021-00282-4_bib38","doi-asserted-by":"crossref","first-page":"7577","DOI":"10.1158\/0008-5472.CAN-09-0773","article-title":"BCL9 promotes tumor progression by conferring enhanced proliferative, metastatic, and angiogenic properties to cancer cells","volume":"69","author":"Mani","year":"2009","journal-title":"Cancer research"},{"key":"10.1186\/s43141-021-00282-4_bib39","doi-asserted-by":"crossref","unstructured":"Takada, K., Zhu, D., Bird, G. H., Sukhdeo, K., Zhao, J.-J., Mani, M., Lemieux, M., Carrasco, D. E., Ryan, J., and Horst, D. (2012) Targeted disruption of the BCL9\/\u03b2-catenin complex inhibits oncogenic Wnt signaling, Science translational medicine 4, 148ra117-148ra117. https:\/\/doi.org\/10.1126\/scitranslmed.3003808","DOI":"10.1126\/scitranslmed.3003808"},{"key":"10.1186\/s43141-021-00282-4_bib40","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1158\/0008-5472.CAN-13-3311-T","article-title":"miR-30-5p functions as a tumor suppressor and novel therapeutic tool by targeting the oncogenic Wnt\/\u03b2-catenin\/BCL9 pathway","volume":"74","author":"Zhao","year":"2014","journal-title":"Cancer research"},{"key":"10.1186\/s43141-021-00282-4_bib41","first-page":"1","article-title":"Loss of BCL9\/9l suppresses Wnt driven tumourigenesis in models that recapitulate human cancer","volume":"10","author":"Gay","year":"2019","journal-title":"Nature communications"},{"key":"10.1186\/s43141-021-00282-4_bib42","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2017.356","article-title":"miR-1301 inhibits hepatocellular carcinoma cell migration, invasion, and angiogenesis by decreasing Wnt\/\u03b2-catenin signaling through targeting BCL9","volume":"8","author":"Yang","year":"2017","journal-title":"Cell death & disease"},{"key":"10.1186\/s43141-021-00282-4_bib43","first-page":"248","article-title":"Determination of cytochrome P450 2D6 (CYP2D6) gene copy number by real-time quantitative PCR","volume":"2005","author":"Bodin","year":"2005","journal-title":"Journal of Biomedicine and Biotechnology"},{"key":"10.1186\/s43141-021-00282-4_bib44","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.cca.2009.03.007","article-title":"TaqMan real-time PCR quantification strategy of CYP2D6 gene copy number for the LightCycler 2.0","volume":"403","author":"Nguyen","year":"2009","journal-title":"Clinica chimica acta"},{"key":"10.1186\/s43141-021-00282-4_bib45","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/nprot.2008.73","article-title":"Analyzing real-time PCR data by the comparative CT method","volume":"3","author":"Schmittgen","year":"2008","journal-title":"Nature protocols"},{"key":"10.1186\/s43141-021-00282-4_bib46","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/hep.31288","article-title":"Epidemiology of hepatocellular carcinoma","volume":"73","author":"McGlynn","year":"2021","journal-title":"Hepatology"},{"key":"10.1186\/s43141-021-00282-4_bib47","unstructured":"Omar A, Abou-Alfa GK, Khairy A, Omar H (2013) Risk factors for developing hepatocellular carcinoma in Egypt. Chinese clinical oncology 2. https:\/\/doi.org\/10.3978\/j.issn.2304-3865.2013.11.07"},{"key":"10.1186\/s43141-021-00282-4_bib48","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jhep.2018.03.019","article-title":"EASL clinical practice guidelines: management of hepatocellular carcinoma","volume":"69","author":"Liver","year":"2018","journal-title":"Journal of hepatology"},{"key":"10.1186\/s43141-021-00282-4_bib49","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1016\/S0140-6736(03)14964-1","article-title":"Hepatocellular carcinoma","volume":"362","author":"Llovet","year":"2003","journal-title":"Lancet (London, England)"},{"key":"10.1186\/s43141-021-00282-4_bib50","doi-asserted-by":"crossref","unstructured":"Mart\u00ednez-Chantar ML, Avila MA, Lu SC (2020) Hepatocellular carcinoma: updates in pathogenesis, detection and treatment. Multidisciplinary Digital Publishing Institute. https:\/\/doi.org\/10.3390\/cancers12102729","DOI":"10.3390\/cancers12102729"},{"key":"10.1186\/s43141-021-00282-4_bib51","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.jhep.2005.12.015","article-title":"Prospective validation of the Barcelona Clinic Liver Cancer staging system","volume":"44","author":"Cillo","year":"2006","journal-title":"Journal of hepatology"},{"key":"10.1186\/s43141-021-00282-4_bib52","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0090929","article-title":"Comparing staging systems for predicting prognosis and survival in patients with hepatocellular carcinoma in Egypt","volume":"9","author":"Gomaa","year":"2014","journal-title":"PloS one"},{"key":"10.1186\/s43141-021-00282-4_bib53","first-page":"411","article-title":"Prognostic factors for survival in patients with early-intermediate hepatocellular carcinoma undergoing non-surgical therapy: comparison of Okuda","volume":"54","author":"Grieco","year":"2005","journal-title":"CLIP, and BCLC staging systems in a single Italian centre, Gut"},{"key":"10.1186\/s43141-021-00282-4_bib54","doi-asserted-by":"crossref","unstructured":"Lee, J. H., Han, S. Y., Jo, J. H., Kim, S. K., Go, B. S., Oh, J. Y., Choi, J. C., Lee, S. W., Jang, J. S., and Roh, M. H. (2007) Prognostic factors for survival in patients with hepatocellular carcinoma after radiofrequency ablation, The Korean journal of gastroenterology= Taehan Sohwagi Hakhoe chi 49, 17-23. https:\/\/doi.org\/10.4166\/kjg.2020.75.1.17","DOI":"10.4166\/kjg.2020.75.1.17"},{"key":"10.1186\/s43141-021-00282-4_bib55","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1002\/hep.20636","article-title":"Prognosis of hepatocellular carcinoma: comparison of 7 staging systems in an American cohort","volume":"41","author":"Marrero","year":"2005","journal-title":"Hepatology"},{"key":"10.1186\/s43141-021-00282-4_bib56","first-page":"3190","article-title":"Expression of Wnt-5a and \u03b2-catenin in primary hepatocellular carcinoma","volume":"7","author":"Li","year":"2014","journal-title":"International journal of clinical and experimental pathology"},{"key":"10.1186\/s43141-021-00282-4_bib57","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s13402-016-0299-z","article-title":"DNA copy number alterations, gene expression changes and disease-free survival in patients with colorectal cancer: a 10 year follow-up","volume":"39","author":"Bigagli","year":"2016","journal-title":"Cellular Oncology"},{"key":"10.1186\/s43141-021-00282-4_bib58","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/j.1745-7254.2005.00126.x","article-title":"Cytogenetic and molecular genetic alterations in hepatocellular carcinoma","volume":"26","author":"Lau","year":"2005","journal-title":"Acta Pharmacologica Sinica"},{"key":"10.1186\/s43141-021-00282-4_bib59","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1002\/hep.26402","article-title":"Genomic landscape of copy number aberrations enables the identification of oncogenic drivers in hepatocellular carcinoma","volume":"58","author":"Wang","year":"2013","journal-title":"Hepatology"},{"key":"10.1186\/s43141-021-00282-4_bib60","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s12072-019-09977-w","article-title":"Wnt status-dependent oncogenic role of BCL9 and BCL9L in hepatocellular carcinoma","volume":"14","author":"Huge","year":"2020","journal-title":"Hepatology international"},{"key":"10.1186\/s43141-021-00282-4_bib61","doi-asserted-by":"crossref","unstructured":"Moghe A, Monga SP (2020) BCL9\/BCL9L in hepatocellular carcinoma: will it or Wnt it be the next therapeutic target? Springer. https:\/\/doi.org\/10.1007\/s12072-020-10059-5","DOI":"10.1007\/s12072-020-10059-5"},{"key":"10.1186\/s43141-021-00282-4_bib62","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0196826","article-title":"A feasibility study of colorectal cancer diagnosis via circulating tumor DNA derived CNV detection","volume":"13","author":"Molparia","year":"2018","journal-title":"PloS one"}],"container-title":["Journal of Genetic Engineering and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43141-021-00282-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s43141-021-00282-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1687157X23009514?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1687157X23009514?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43141-021-00282-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T13:42:40Z","timestamp":1761658960000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1687157X23009514"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":62,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["S1687157X23009514"],"URL":"https:\/\/doi.org\/10.1186\/s43141-021-00282-4","relation":{},"ISSN":["1687-157X"],"issn-type":[{"type":"print","value":"1687-157X"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of BCL9 genetic variation as a biomarker for hepatitis C-related hepatocellular carcinoma in Egyptian patients","name":"articletitle","label":"Article Title"},{"value":"Journal of Genetic Engineering and Biotechnology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1186\/s43141-021-00282-4","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Academy of Scientific Research and Technology. Published by Elsevier BV.","name":"copyright","label":"Copyright"}],"article-number":"4"}}